SEC
SlamSEC
Search
Browse
Earnings
Singular Genomics Systems, Inc. — SlamSEC
Singular Genomics Systems, Inc.
Laboratory Analytical Instruments
·
SAN DIEGO, CA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
$765,000
FY 2023
Adj. EBITDA
-$91.1M
-11902.7% margin
FY 2023
Net Income
-$90.9M
-11879.6% margin
FY 2023
EPS (Diluted)
-$1.28
FY 2023
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$74.3M
FY 2023
Total Debt
$10.1M
FY 2023
Net Cash
$64.2M
FY 2023
Enterprise Value
—
Debt / EBITDA
0.7x
FY 2023
EV / EBITDA
—
Employees
—